Similar articles for PMID: 28254117

Year	Number of Results
1902	1
1932	1
1934	1
1935	1
1942	1
1946	10
1947	5
1948	4
1949	8
1950	1
1951	1
1952	4
1953	2
1954	2
1955	7
1956	6
1961	1
1968	1
1972	2
1974	2
1975	2
1977	4
1978	1
1979	2
1980	2
1983	4
1984	3
1985	1
1986	1
1987	3
1988	2
1989	2
1990	1
1991	2
1993	2
1994	1
1996	1
1999	3
2000	4
2001	3
2002	10
2003	11
2004	4
2005	2
2006	8
2007	8
2008	6
2009	1
2010	3
2011	11
2012	23
2013	27
2014	16
2015	20
2016	14
2017	22
2018	11
2019	14
2020	16
2021	9
2022	11
2023	2
2024	0

1

Correlation of benign prostatic obstruction-related complications with clinical outcomes in patients after transurethral resection of the prostate.

Guo RQ, Yu W, Meng YS, Zhang K, Xu B, Xiao YX, Wu SL, Pan BN. Guo RQ, et al. Kaohsiung J Med Sci. 2017 Mar;33(3):144-151. doi: 10.1016/j.kjms.2017.01.002. Epub 2017 Feb 13. Kaohsiung J Med Sci. 2017. PMID: 28254117 Free article.

2

Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).

Elshal AM, Elmansy HM, Elhilali MM. Elshal AM, et al. BJU Int. 2012 Dec;110(11 Pt C):E845-50. doi: 10.1111/j.1464-410X.2012.11290.x. Epub 2012 Jun 15. BJU Int. 2012. PMID: 22702908

3

A Multicenter Randomized Noninferiority Trial Comparing GreenLight-XPS Laser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH Study.

Thomas JA, Tubaro A, Barber N, d'Ancona F, Muir G, Witzsch U, Grimm MO, Benejam J, Stolzenburg JU, Riddick A, Pahernik S, Roelink H, Ameye F, Saussine C, Bruyère F, Loidl W, Larner T, Gogoi NK, Hindley R, Muschter R, Thorpe A, Shrotri N, Graham S, Hamann M, Miller K, Schostak M, Capitán C, Knispel H, Bachmann A. Thomas JA, et al. Eur Urol. 2016 Jan;69(1):94-102. doi: 10.1016/j.eururo.2015.07.054. Epub 2015 Aug 15. Eur Urol. 2016. PMID: 26283011 Clinical Trial.

4

BiVap saline vaporization of the prostate in men with benign prostatic hyperplasia: our clinical experience.

Karakose A, Aydogdu O, Atesci YZ. Karakose A, et al. Urology. 2014 Mar;83(3):570-5. doi: 10.1016/j.urology.2013.10.014. Epub 2013 Nov 22. Urology. 2014. PMID: 24275275

5

Laser transurethral resection of the prostate: Safety study of a novel system of photoselective vaporization with high power diode laser in prostates larger than 80mL.

Andrés G, Arance I, Gimbernat H, Redondo C, García-Tello A, Angulo JC. Andrés G, et al. Actas Urol Esp. 2015 Jul-Aug;39(6):375-82. doi: 10.1016/j.acuro.2014.10.007. Epub 2015 Mar 6. Actas Urol Esp. 2015. PMID: 25745792 Clinical Trial. English, Spanish.

6

180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study.

Bachmann A, Tubaro A, Barber N, d'Ancona F, Muir G, Witzsch U, Grimm MO, Benejam J, Stolzenburg JU, Riddick A, Pahernik S, Roelink H, Ameye F, Saussine C, Bruyère F, Loidl W, Larner T, Gogoi NK, Hindley R, Muschter R, Thorpe A, Shrotri N, Graham S, Hamann M, Miller K, Schostak M, Capitán C, Knispel H, Thomas JA. Bachmann A, et al. Eur Urol. 2014 May;65(5):931-42. doi: 10.1016/j.eururo.2013.10.040. Epub 2013 Nov 11. Eur Urol. 2014. PMID: 24331152 Clinical Trial.

7

Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.

Seki N, Yunoki T, Tomoda T, Takei M, Yamaguchi A, Naito S. Seki N, et al. Neurourol Urodyn. 2008;27(3):222-5. doi: 10.1002/nau.20466. Neurourol Urodyn. 2008. PMID: 17580358

8

WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation^® vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia.

Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T, Kramolowsky E, Thomas A, Cowan B, Kaufman RP Jr, Trainer A, Arther A, Badlani G, Plante M, Desai M, Doumanian L, Te AE, DeGuenther M, Roehrborn C. Gilling P, et al. J Urol. 2018 May;199(5):1252-1261. doi: 10.1016/j.juro.2017.12.065. Epub 2018 Jan 31. J Urol. 2018. PMID: 29360529 Clinical Trial.

9

Transurethral resection of the prostate provides more favorable clinical outcomes compared with conservative medical treatment in patients with urinary retention caused by benign prostatic obstruction.

Lin YH, Hou CP, Chen TH, Juang HH, Chang PL, Yang PS, Chen CL, Tsui KH. Lin YH, et al. BMC Geriatr. 2018 Jan 16;18(1):15. doi: 10.1186/s12877-018-0709-3. BMC Geriatr. 2018. PMID: 29338688 Free PMC article.

10

[Value of transurethral resection of the prostate (TURP) for treatment of symptomatic benign prostatic obstruction (BPO): an analysis of efficiency and complications in 1015 cases].

Zepnick H, Steinbach F, Schuster F. Zepnick H, et al. Aktuelle Urol. 2008 Sep;39(5):369-72. doi: 10.1055/s-2008-1038222. Epub 2008 Sep 16. Aktuelle Urol. 2008. PMID: 18798126 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

317 results

Results by year